Boss, David S.
University of California, Los Angeles · Pfizer (United States) · Utrecht University · Ronald Reagan UCLA Medical Center · UCLA Medical Center · The Netherlands Cancer Institute · Dana-Farber Cancer Institute · Pfizer (China) · University of Colorado Denver
2 papers on CoChat
Most cited papers
- Verified
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 3,634
- Verified
Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors
Jänne, P. A., Boss, D. S., Camidge, D. R., Britten, C. D., Engelman, J. A., Garon, E. B., Guo, F., Wong, S., Liang, J., Letrent, S., et al. (2011) · Clinical Cancer Research
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 181
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free